MARK2 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A known kinase inhibitor that can inhibit MARK2 by binding to the ATP pocket, thereby blocking its kinase activity. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
An adenosine analog that can inhibit MARK2 by competing with ATP, thus preventing phosphorylation events necessary for MARK2's activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A broad-spectrum kinase inhibitor that may inhibit MARK2 alongside other kinases by altering the phosphorylation state, affecting signaling pathways. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
A cyclin-dependent kinase inhibitor that may indirectly affect MARK2's regulatory network by modulating cell cycle-related kinases. | ||||||
Sotrastaurin | 425637-18-9 | sc-474229 sc-474229A | 5 mg 10 mg | $300.00 $540.00 | ||
A protein kinase C inhibitor that may also impact MARK2 function due to cross-talk between PKC and MARK2 signaling pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A class of compounds known for PKC inhibition which may also have off-target effects on MARK2 due to structural similarities in their ATP-binding regions. | ||||||
Kenpaullone | 142273-20-9 | sc-200643 sc-200643A sc-200643B sc-200643C | 1 mg 5 mg 10 mg 25 mg | $61.00 $153.00 $231.00 $505.00 | 1 | |
Another cyclin-dependent kinase inhibitor that could have an impact on MARK2 through modulation of the cell cycle and associated kinases. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
Reported as a CK1 inhibitor but due to the conserved nature of the kinase ATP binding site, it may also inhibit MARK2. | ||||||
PF-4800567 Hydrochloride | 1391052-28-0 | sc-477581 | 10 mg | $320.00 | ||
A selective inhibitor of MARK2 that competes with ATP binding, thus directly inhibiting its kinase activity. | ||||||
SCH772984 | 942183-80-4 | sc-473205 | 5 mg | $370.00 | 5 | |
An ERK inhibitor that can indirectly affect MARK2 activity through the MAPK signaling pathway, which is interconnected with MARK2s function. | ||||||